All of the following may cause cycloplegia except?
Which antiviral drug is used for the treatment of cytomegalovirus retinitis?
What is the concentration of xylocaine used for tonometry?
All of the following drugs can cause anterior uveitis except?
Latanoprost used topically in glaucoma primarily acts by?
Pigment deposition on the cornea is seen in which of the following conditions?
Which anti-glaucoma drug can induce pigmentation of the iris?
Which of the following drugs is not used topically for the treatment of open-angle glaucoma?
Which of the following drugs can lead to Cystoid Macular Edema?
Which is the shortest acting mydriatic?
Explanation: **Explanation:** The core concept behind this question is the distinction between **parasympatholytics** (antimuscarinics) and **parasympathomimetics** (cholinergics). **Why Physostigmine is the correct answer:** Physostigmine is an **indirect-acting cholinergic agonist** (anticholinesterase). It inhibits the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine at the motor endplate. In the eye, this causes contraction of the ciliary muscle (**accommodation**) and the sphincter pupillae (**miosis**). Therefore, it causes a spasm of accommodation rather than cycloplegia (paralysis of accommodation). **Why the other options are incorrect:** * **Atropine, Cyclopentolate, and Tropicamide** are all **muscarinic antagonists** (parasympatholytics). They block the M3 receptors on the ciliary muscle, leading to paralysis of the ciliary muscle (**cycloplegia**) and the sphincter pupillae (**mydriasis**). * **Atropine** is the most potent and longest-acting (7–10 days). * **Tropicamide** is the shortest-acting (4–6 hours), making it ideal for routine fundus examinations. * **Cyclopentolate** has an intermediate duration (24 hours) and is the drug of choice for cycloplegic refraction in children. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for cycloplegic refraction:** * Infants (<1 year): Atropine ointment. * Children (1–5 years): Atropine or Cyclopentolate. * School-age children/Adolescents: Cyclopentolate. * **Mnemonic for Anticholinergic Side Effects:** "Hot as a hare, red as a beet, dry as a bone, blind as a bat (cycloplegia), and mad as a hatter." * **Physostigmine** is also the specific antidote for Atropine poisoning.
Explanation: **Explanation:** **1. Why Ganciclovir is the Correct Answer:** Cytomegalovirus (CMV) retinitis is the most common opportunistic ocular infection in patients with AIDS (typically when CD4 counts fall below 50 cells/µL). **Ganciclovir** is a nucleoside analogue that specifically inhibits CMV DNA polymerase. It is the gold standard treatment and can be administered intravenously, orally (Valganciclovir), or via intravitreal injection/implant. Other drugs used for CMV retinitis include **Foscarnet** and **Cidofovir**. **2. Why the Other Options are Incorrect:** * **Acyclovir (Option A):** While effective against Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), Acyclovir has very poor activity against CMV because CMV lacks the viral thymidine kinase enzyme required to activate the drug. * **Trifluridine (Option C):** This is a topical antiviral used primarily for the treatment of **Herpetic Keratitis** (dendritic ulcers). It is too toxic for systemic use and does not reach therapeutic levels in the retina to treat CMV. **3. Clinical Pearls for NEET-PG:** * **Classic Appearance:** CMV retinitis presents as **"Pizza-pie retinopathy"** or "Cottage cheese with ketchup" appearance (areas of white retinal necrosis with associated hemorrhage). * **Side Effect:** The most significant dose-limiting side effect of systemic Ganciclovir is **bone marrow suppression** (neutropenia). * **Differential Diagnosis:** Do not confuse CMV retinitis with **ARN (Acute Retinal Necrosis)**, which is caused by HSV/VZV and *is* treated with Acyclovir. * **Drug of Choice:** Oral **Valganciclovir** is now preferred for induction and maintenance therapy due to its high bioavailability.
Explanation: **Explanation:** In ophthalmic practice, **4% Xylocaine (Lidocaine)** is the standard concentration used for rapid surface anesthesia. For procedures like **Goldmann Applanation Tonometry (GAT)**, which requires direct contact with the cornea, a potent and fast-acting anesthetic is necessary to abolish the blink reflex and eliminate pain. * **Why 4% is correct:** While lower concentrations (1-2%) are effective for infiltration or nerve blocks, the corneal epithelium acts as a significant barrier. A higher concentration of **4%** ensures rapid penetration and a deep enough level of topical anesthesia (usually within 30–60 seconds) to allow the tonometer prism to touch the cornea without discomfort. It is frequently used in combination with **fluorescein dye** (either as a premixed solution or separately) to visualize the mires during tonometry. * **Why other options are incorrect:** * **1% and 2% Xylocaine:** These concentrations are primarily used for **local infiltration** (e.g., lid surgery) or **regional nerve blocks** (e.g., Peribulbar or Retrobulbar anesthesia). They are generally too weak for effective, rapid-onset topical corneal anesthesia. * **3% Xylocaine:** This is not a standard commercial preparation used in routine ophthalmic practice. **Clinical Pearls for NEET-PG:** 1. **Other Topical Anesthetics:** Proparacaine (0.5%) and Tetracaine (0.5%) are also commonly used for tonometry; Proparacaine is often preferred as it causes less stinging than Xylocaine. 2. **Toxicity:** Repeated use of topical anesthetics is **contraindicated** as it causes "corneal melting" (toxic epithelial keratopathy) and inhibits epithelial healing. 3. **Gold Standard:** Goldmann Applanation Tonometry remains the gold standard for measuring Intraocular Pressure (IOP).
Explanation: **Explanation:** The correct answer is **Chloroquine**. In ophthalmic pharmacology, understanding drug-induced uveitis is crucial for NEET-PG. **Why Chloroquine is the correct answer:** Chloroquine (and Hydroxychloroquine) is primarily known for causing **retinal toxicity**, specifically "Bull’s eye maculopathy," due to its affinity for melanin in the Retinal Pigment Epithelium (RPE). It does **not** typically cause anterior uveitis. Its anterior segment side effect is limited to **Vortex Keratopathy** (Cornea Verticillata), which is characterized by fine, whorl-like epithelial deposits. **Analysis of other options:** * **Metoprolol:** While rare, systemic Beta-blockers (and more commonly, topical ones like Timolol) have been associated with drug-induced uveitis through immune-mediated mechanisms. * **Brimonidine:** This Alpha-2 agonist is a well-known cause of **granulomatous anterior uveitis**, often occurring months after starting the medication. It is frequently associated with follicular conjunctivitis. * **Cidofovir:** This antiviral (used for CMV retinitis) is a classic cause of severe **fibrinous anterior uveitis** and hypotony. It is often co-administered with oral Probenecid to reduce this risk. **High-Yield Clinical Pearls for NEET-PG:** * **Common drugs causing Anterior Uveitis:** Cidofovir, Rifabutin (classic triad: fever, arthralgia, uveitis), Brimonidine, Bisphosphonates (Zoledronate), and Sulfonamides. * **Vortex Keratopathy Mnemonic (CHAI-T):** **C**hloroquine, **H**ydroxychloroquine, **A**miodarone, **I**ndomethacin, **T**amoxifen (and Fabry’s disease). * **Brimonidine** is contraindicated in children under 2 years due to the risk of CNS depression and apnea.
Explanation: ### Explanation **Latanoprost** is a Prostaglandin F2α (PGF2α) analogue and is currently considered the first-line medical therapy for Primary Open-Angle Glaucoma (POAG). **Mechanism of Action (Why B is correct):** Latanoprost acts as a selective agonist at the **FP receptors** located in the ciliary muscle. Stimulation of these receptors leads to the induction of matrix metalloproteinases (MMPs), which remodel the extracellular matrix and increase the permeability of the ciliary muscle fibers. This results in a significant increase in **uveoscleral outflow** (the non-conventional pathway), thereby lowering intraocular pressure (IOP). **Analysis of Incorrect Options:** * **A. Decreasing aqueous humor formation:** This is the mechanism of **Beta-blockers** (e.g., Timolol), **Alpha-2 agonists** (e.g., Brimonidine), and **Carbonic Anhydrase Inhibitors** (e.g., Acetazolamide). * **C. Releasing pupillary block:** This is achieved via **Miotics** (e.g., Pilocarpine) or surgical/laser peripheral iridotomy, primarily used in Angle-Closure Glaucoma. * **D. Increasing trabecular outflow:** This is the primary mechanism of **Miotics** (Pilocarpine), which pull the scleral spur to open the trabecular meshwork, and newer agents like **Rho-kinase inhibitors** (Netarsudil). **High-Yield Clinical Pearls for NEET-PG:** * **Dosing:** Once-daily (OD) at night (better efficacy and compliance). * **Side Effects:** * **Iris heterochromia:** Permanent darkening of iris color (increased melanin in melanocytes). * **Hypertrichosis:** Increased length and thickness of eyelashes. * **Cystoid Macular Edema (CME):** Use with caution in aphakic or pseudophakic patients. * **Prostaglandin-associated periorbitopathy:** Loss of periorbital fat. * **Contraindication:** Active intraocular inflammation (Uveitis), as prostaglandins are pro-inflammatory mediators.
Explanation: **Explanation:** **Chloroquine toxicity** is the correct answer because this drug has a high affinity for melanin-containing tissues. In the cornea, chloroquine (and hydroxychloroquine) deposits in the basal layer of the epithelium, leading to a condition known as **Vortex Keratopathy** (also called **Cornea Verticillata**). This appears as fine, golden-brown or greyish-pigmented deposits arranged in a whorl-like pattern. While these corneal deposits are usually asymptomatic and reversible upon discontinuation, they serve as a clinical marker for potential systemic toxicity. **Analysis of Incorrect Options:** * **Digoxin toxicity:** Primarily causes visual disturbances known as **Dyschromatopsia** (specifically **Xanthopsia**, where objects appear yellow). It does not cause physical pigment deposition on the cornea. * **Ranitidine side effect:** This H2-receptor antagonist is not associated with any specific corneal pigmentary changes or significant ocular toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Cornea Verticillata (Whorl Keratopathy) Mnemonic:** "CHAI-T" * **C**hloroquine/Hydroxychloroquine * **H**eiodarone (Amiodarone) - Most common cause * **A**tovaquone * **I**ndomethacin * **T**amoxifen (also **Fabry’s Disease**, an X-linked metabolic disorder) * **Chloroquine Retinopathy:** Characterized by a **"Bull’s Eye Maculopathy"** due to RPE atrophy sparing the fovea. * **Amiodarone:** Causes both Cornea Verticillata and anterior subcapsular lens opacities.
Explanation: **Explanation:** **Latanoprost** is the correct answer. It belongs to the **Prostaglandin Analogues (PGAs)** class, which are first-line agents in the management of Primary Open-Angle Glaucoma (POAG). **Mechanism of Pigmentation:** Latanoprost induces iris pigmentation by increasing the **melanin content** within the stromal melanocytes of the iris. It is important to note that it does not cause melanocyte proliferation (hyperplasia); rather, it stimulates **melanogenesis**. This effect is most common in individuals with multi-colored irides (e.g., hazel or blue-brown eyes) and is usually permanent. **Analysis of Incorrect Options:** * **A. Timolol:** A non-selective beta-blocker. Its primary side effects are systemic (bradycardia, bronchospasm) and local (stinging, dry eye), but it does not affect iris color. * **B. Prednisolone:** A corticosteroid. While it can cause a secondary rise in intraocular pressure (steroid-induced glaucoma) and posterior subcapsular cataracts, it does not cause iris pigmentation. * **D. Olopatadine:** An antihistamine/mast cell stabilizer used for allergic conjunctivitis. It has no role in glaucoma management or iris color changes. **High-Yield Clinical Pearls for NEET-PG:** * **Other PGA Side Effects:** Hypertrichosis (increased eyelash growth), darkening of eyelashes, deepening of the upper eyelid sulcus (prostaglandin-associated periorbitopathy), and reactivation of Herpetic keratitis. * **Mechanism of Action:** PGAs lower IOP by increasing **uveoscleral outflow**. * **Contraindication:** Relative contraindication in inflammatory glaucoma (uveitic glaucoma) and cystoid macular edema (CME).
Explanation: **Explanation:** The correct answer is **Acetazolamide** because of its **route of administration**. While it is a potent Carbonic Anhydrase Inhibitor (CAI) used to reduce intraocular pressure (IOP), it is administered **systemically** (oral or intravenous), not topically. **Analysis of Options:** * **Acetazolamide (Option C):** It is a systemic CAI. Due to its significant systemic side effects (paresthesia, metabolic acidosis, hypokalemia, and renal stones), it is generally reserved for short-term management of acute angle-closure glaucoma or as a temporary measure before surgery, rather than long-term topical therapy for open-angle glaucoma. * **Latanoprost (Option A):** A Prostaglandin F2α analogue. It is used **topically** once daily and is currently the first-line treatment for open-angle glaucoma due to its superior efficacy in increasing uveoscleral outflow. * **Brimonidine (Option B):** A selective Alpha-2 agonist used **topically**. It works by decreasing aqueous production and increasing uveoscleral outflow. It also has potential neuroprotective properties. * **Dorzolamide (Option D):** A **topical** Carbonic Anhydrase Inhibitor. It was developed specifically to provide the IOP-lowering benefits of CAIs while avoiding the systemic side effects associated with acetazolamide. **High-Yield Clinical Pearls for NEET-PG:** * **First-line drug for POAG:** Prostaglandin analogues (e.g., Latanoprost). * **Side effect of Latanoprost:** Iris hyperpigmentation, thickening of eyelashes, and cystoid macular edema. * **Side effect of Brimonidine:** Follicular conjunctivitis; it is contraindicated in infants due to the risk of CNS depression/apnea. * **Drug of choice for Acute Angle Closure Glaucoma:** IV Mannitol (osmotic agent) and Acetazolamide.
Explanation: **Explanation:** **Cystoid Macular Edema (CME)** is a condition characterized by the accumulation of fluid in the Henle’s layer of the macula, often presenting as a "flower-petal" pattern on Fundus Fluorescein Angiography (FFA). **Why Latanoprost is correct:** Latanoprost is a **Prostaglandin Analogue (PGA)**. PGAs are known to increase the levels of endogenous prostaglandins, which can lead to a breakdown of the blood-aqueous barrier and the blood-retinal barrier. This increased permeability results in fluid leakage into the macula. This side effect is most commonly observed in **aphakic** or **pseudophakic** patients (especially those with a posterior capsular rent). **Analysis of Incorrect Options:** * **Dipevefrine:** This is a prodrug of epinephrine. While epinephrine is classically associated with CME in aphakic eyes (Irvine-Gass Syndrome), Dipevefrine is less commonly implicated in modern clinical practice compared to PGAs. * **Timolol:** A non-selective beta-blocker. Its primary side effects are systemic (bradycardia, bronchospasm) and local (dry eye, stinging); it does not cause CME. * **Brinzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). Interestingly, CAIs (like Acetazolamide) are actually used to **treat** certain types of macular edema by enhancing the pumping function of the Retinal Pigment Epithelium (RPE). **High-Yield Clinical Pearls for NEET-PG:** * **Drug-induced CME Mnemonic (L-A-D-E-N):** **L**atanoprost, **A**drenaline (Epinephrine), **D**ipivefrin, **E**zetimibe, **N**iacin (Nicotinic acid). * **Docetaxel** (Taxanes) can also cause a unique form of CME without leakage on FFA. * **Gold Standard Investigation:** Optical Coherence Tomography (OCT) is the investigation of choice, showing cystic spaces in the macula.
Explanation: **Explanation:** The duration of action of mydriatic and cycloplegic drugs is a high-yield topic in Ophthalmology. These drugs are **anti-muscarinic agents** that block the M3 receptors on the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia). **Why Tropicamide is correct:** Tropicamide is a synthetic parasympatholytic with the **fastest onset and shortest duration of action**. It typically produces mydriasis within 20–30 minutes, and its effects wear off in **4 to 6 hours**. This makes it the drug of choice for routine fundus examinations, as it allows the patient to recover normal vision and light sensitivity quickly. **Analysis of Incorrect Options:** * **Atropine:** This is the **longest-acting** agent. Its effects can last for **7 to 12 days**. It is primarily used for treating uveitis or for refraction in children under 5 years (due to its potent cycloplegic effect). * **Homatropine:** A semi-synthetic alkaloid with an intermediate duration of action, lasting **2 to 3 days**. It is often used in the management of anterior uveitis to prevent synechiae. * **Cyclopentolate:** This agent has a duration of action of approximately **24 hours**. It is the drug of choice for cycloplegic refraction in children and adolescents. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Duration (Shortest to Longest):** Tropicamide (6 hrs) < Cyclopentolate (24 hrs) < Homatropine (2-3 days) < Atropine (7-10 days). * **Drug of Choice for Fundoscopy:** Tropicamide (due to rapid recovery). * **Drug of Choice for Refraction in Children:** Cyclopentolate (Atropine is preferred if the child has strabismus/accommodative esotropia). * **Side Effect Note:** All these agents can precipitate **Acute Angle Closure Glaucoma** in patients with narrow anterior chamber angles.
Ocular Pharmacokinetics
Practice Questions
Anti-infective Agents
Practice Questions
Anti-inflammatory Drugs
Practice Questions
Antiglaucoma Medications
Practice Questions
Mydriatics and Cycloplegics
Practice Questions
Ocular Lubricants
Practice Questions
Anti-VEGF Agents
Practice Questions
Ocular Diagnostic Agents
Practice Questions
Anesthetics in Ophthalmology
Practice Questions
Preservatives and Their Effects
Practice Questions
Ocular Toxicology
Practice Questions
Novel Drug Delivery Systems
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free